Deficiency of hMLH1 and hMSH2 expression is a poor prognostic factor in esophageal squamous cell carcinoma

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Surgical Oncology

• Publication date

  2005-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jso.20332PMID 16231369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic and epigenetic modification of mismatch repair genes hMSH2 and hMLH1 in sporadic breast cancer with microsatellite instability

  2002cited by this paper
• Immunohistochemical Pattern of MLH1/MSH2 Expression Is Related to Clinical and Pathological Features in Colorectal Adenocarcinomas with Microsatellite Instability

  2002cited by this paper
• Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors.

  2002cited by this paper
• Skeletonizing En Bloc Esophagectomy for Cancer

  2001influential reference
• Microsatellite instability and hMLH1/hMSH2 expression in Barrett esophagus‐associated adenocarcinoma

  2001cited by this paper
• Improvement in the Results of Surgical Treatment of Advanced Squamous Esophageal Carcinoma During 15 Consecutive Years

  2000influential reference
• Correlation of genetic instability with mismatch repair protein expression and p53 mutations in non-small cell lung cancer.

  2000cited by this paper
• Immunohistochemical pattern of hMSH2/hMLH1 in familial and sporadic colorectal, gastric, endometrial and ovarian carcinomas with instability in microsatellite sequences

  2000cited by this paper
• Cancer risk in mutation carriers of DNA‐mismatch‐repair genes

  1999cited by this paper
• Immunohistochemical Analysis of DNA ‘mismatch-repair’ Enzyme Human Mut-S-Homologon-2 in Ovarian Carcinomas

  1999cited by this paper
• Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair

  1999cited by this paper
• Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors.

  1999cited by this paper
• Replication errors: cha(lle)nging the genome

  1998cited by this paper
• Infrequent frameshift mutations of polynucleotide repeats in multiple primary cancers affecting the esophagus and other organs

  1998cited by this paper
• Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease.

  1998cited by this paper
• Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.

  1998cited by this paper
• Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany.

  1997cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients

  1996cited by this paper
• Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues.

  1996cited by this paper
• Mismatch repair defects in human carcinogenesis.

  1996cited by this paper
• Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.

  1993cited by this paper
• Genetic instability of microsatellites in endometrial carcinoma.

  1993cited by this paper
• Comparison of characteristics of esophageal squamous cell carcinoma associated with head and neck cancer and those with gastric cancer

  1991cited by this paper
• Smoking and drinking in relation to cancers of the oral cavity, pharynx, larynx, and esophagus in northern Italy.

  1990cited by this paper

• Advances in diagnostic and therapeutic applications of mismatch repair loss in cancer

  2025cites this paper
• MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma

  2023cites this paper
• PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma

  2022cites this paper
• MutSα expression predicts a lower disease-free survival in malignant salivary gland tumors: an immunohistochemical study

  2022cites this paper
• Genetic and molecular bases of esophageal Cancer among Iranians: an update

  2019cites this paper
• Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategy

  2019cites this paper
• Esophageal cancer genetics in South Africa

  2019cites this paper
• Predictive and prognostic implications of microsatellite instability and mismatch repair deficiency in carcinomas of the gastrointestinal tract, liver, and pancreas

  2019cites this paper
• Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study

  2018cites this paper
• Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview

  2018cites this paper
• Expression of methylation-modulated tumor-related genes in endoscopically resected early esophageal squamous neoplasia

  2017cites this paper
• Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review

  2017cites this paper
• Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma.

  2017cites this paper
• Overexpression of MutSα Complex Proteins Predicts Poor Prognosis in Oral Squamous Cell Carcinoma

  2016cites this paper
• High UBCH10 protein expression as a marker of poor prognosis in esophageal squamous cell carcinoma.

  2014cites this paper
• Interplay among epigenetic alterations and crosstalk between genetic and epigenetic alterations in esophageal squamous cell carcinoma

  2014cites this paper
• Deficiency of MSH2 expression is associated with clear cell renal cell carcinoma

  2014cites this paper
• Expression of natriuretic peptide receptor-A in esophageal squamous cell carcinomas and the relationship with tumor invasion and migration

  2014cites this paper
• Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer.

  2014cites this paper
• MLH1 as a Direct Target of MiR-155 and a Potential Predictor of Favorable Prognosis in Pancreatic Cancer

  2013cites this paper
• IDENTIFICATION OF GENETIC POLYMORPHISMS ASSOCIATED WITH OESOPHAGEAL SQUAMOUS CELL CARCINOMA RISK IN SOUTH AFRICA

  2013cites this paper
• The Cumulative Effects of Polymorphisms in the DNA Mismatch Repair Genes and Tobacco Smoking in Oesophageal Cancer Risk

  2012cites this paper
• EXPRESSION OF HUMAN CORONAVIRUS NL63 AND SARS-CoV NUCLEOCAPSID PROTEINS FOR ANTIBODY PRODUCTION

  2012cites this paper
• Molecular profiling of oesophageal squamous cell carcinomas in the South African population

  2012cites this paper
• MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma.

  2012cites this paper
• Progress in Susceptibility Genes of Esophageal Cancer

  2012cites this paper
• Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.

  2011cites this paper
• Analysis of the hMSH2 Gene Variants in Head and Neck Cancer

  2010cites this paper
• Loss of hMSH2 gene expression correlates with improved survival in patients with sporadic colorectal cancer

  2010cites this paper
• DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer.

  2010cites this paper
• Expression and Prognostic Roles of Eag1 in Resected Esophageal Squamous Cell Carcinomas

  2008cites this paper
• DNA repair dysfunction in gastrointestinal tract cancers

  2008cites this paper
• Immunoexpression of hMSH2 and hMLH1 in oral squamous cell carcinoma and its relationship to histological grades of malignancy.

  2008cites this paper
• Overexpression of hERG1 in resected esophageal squamous cell carcinomas: A marker for poor prognosis

  2008cites this paper
• A change in promoter methylation of hMLH1 is a cause of acquired resistance to platinum-based chemotherapy in epithelial ovarian cancer.

  2007cites this paper
• Predictive factors in esophageal carcinoma.

  2006cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 147 Predictive Factors in Esophageal Carcinoma

  2006cites this paper